Evidence map›Paper›PMID 33155043›Full record

ArticleBrain : a journal of neurology2020

Somatic TARDBP variants as a cause of semantic dementia.

Jeroen van Rooij, Merel O Mol, Shamiram Melhem, Pelle van der Wal, Pascal Arp, Francesca Paron, Laura Donker Kaat, Harro Seelaar, Netherlands Brain Bank, Suzanne S M Miedema and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Frontotemporal lobar degeneration.Nature reviews. Disease primers · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Jeroen van RooijDepartment of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Merel O MolDepartment of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Shamiram MelhemDepartment of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Pelle van der WalDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Pascal ArpDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Francesca ParonInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Laura Donker KaatDepartment of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Harro SeelaarDepartment of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Netherlands Brain Bank
Suzanne S M MiedemaCenter for Neurogenomics and Cognitive Research, VU University, Amsterdam, The Netherlands.
Takuya OshimaDepartment of Biomedical Sciences of Cells and Systems, section Molecular Neurobiology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Bart J L EggenDepartment of Biomedical Sciences of Cells and Systems, section Molecular Neurobiology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
André UitterlindenDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Joyce van MeursDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Ronald E van KesterenCenter for Neurogenomics and Cognitive Research, VU University, Amsterdam, The Netherlands.
August B SmitCenter for Neurogenomics and Cognitive Research, VU University, Amsterdam, The Netherlands.
Emanuele BurattiInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
John C van SwietenDepartment of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLUniversity Medical Center Groningen · NLAmsterdam UMC Location Vrije Universiteit Amsterdam · NLInternational Centre for Genetic Engineering and Biotechnology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aetiology of late-onset neurodegenerative diseases is largely unknown. Here we investigated whether de novo somatic variants for semantic dementia can be detected, thereby arguing for a more general role of somatic variants in neurodegenerative disease. Semantic dementia is characterized by a non-familial occurrence, early onset (<65 years), focal temporal atrophy and TDP-43 pathology. To test whether somatic variants in neural progenitor cells during brain development might lead to semantic dementia, we compared deep exome sequencing data of DNA derived from brain and blood of 16 semantic dementia cases. Somatic variants observed in brain tissue and absent in blood were validated using amplicon sequencing and digital PCR. We identified two variants in exon one of the TARDBP gene (L41F and R42H) at low level (1-3%) in cortical regions and in dentate gyrus in two semantic dementia brains, respectively. The pathogenicity of both variants is supported by demonstrating impaired splicing regulation of TDP-43 and by altered subcellular localization of the mutant TDP-43 protein. These findings indicate that somatic variants may cause semantic dementia as a non-hereditary neurodegenerative disease, which might be exemplary for other late-onset neurodegenerative disorders.

Indexed as

Alternative SplicingBrain ChemistryDNADNA-Binding ProteinsExomeExome SequencingExonsFemaleFrontotemporal DementiaGenetic VariationGerm-Line MutationHumansMaleMiddle AgedMutationSemanticsDNADNA-Binding ProteinsTARDBP protein, humansemantic dementiasomatic variantsTARDBPTDP-43

Identifiers

PMID33155043
PMCPMC7805802
OpenAlexW3095676416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.